Grape King Bio Ltd (葡萄王), a supplier of probiotics and mushroom mycelium health foods, yesterday inked a three-year cooperation pact with China-based traditional Chinese medicine maker Yunnan Baiyao Group Co (雲南白藥) to codevelop new products and sell products in the Chinese and Southeast Asian markets.
The two companies are currently codeveloping two healthy drink products, one ointment and one pill, Grape King Bio said.
The two companies will jointly launch a health drink in Taiwan at the end of September, ahead of future launches in China and SouthEast Asia next year, Grape King Bio executive vice president Andrew Tseng (曾盛麟) said yesterday.
The company has the rights to sell products codeveloped by both in Taiwan, he said.
Yesterday’s deal also allows Grape King Bio to manufacture products for Yunnan Baiyao Group on a contract basis, while using raw materials provided by the Chinese firm in the new products.
The company will use its factories in Taiwan and Shanghai to make products for Yunnan Baiyao Group, he said.
Meanwhile, Grape King Bio can rely on Yunnan Baiyao Group’s retail channels in China and other oversea markets, including Southeast Asia, to sell its health food products that use raw materials from Yunnan Baiyao Group, Tseng said.
“As most of our revenue currently comes from the domestic market, the deal marks the entrance for Grape King Bio into the international market,” Tseng said.
According to Tseng, Grape King Bio tried to sell its “Come Best” tonic drink, products for improving digestion and mushroom mycelium health foods in China in the past without much success because it lacked a retail network.
The cooperation with Yunnan Baiyao Group may enable the company to enter the market more easily, he said.
Yunnan Baiyao Group is a Shenzhen-listed company with revenue of 15.8 billion yuan (US$2.54 billion) last year, and its market value, which was 82.8 billion yuan in October last year, was the highest among all Chinese medicine makers.
“It is the first time for Yunnan Baiyao Group to sign such a comprehensive cooperation pact with another company,” Tseng said.
From January through May, Grape King Bio posted revenue of NT$2.47 billion (US$82.52 million), up 8.34 percent from NT$2.28 billion a year ago, according to the company’s filing to the Taiwan Stock Exchange.
About 90 percent of its revenue was from Pro-Partner Inc (葡眾), a multi-level marketing company which sells Grape King Bio’s products in Taiwan, Tseng said.
Grape King Bio owns 60 percent of shares of Pro-Partner.
“It is a little bit risky for us to rely on Pro-Partner entirely,” Tseng said. “The cooperation with Yunnan Baiyao Group can become the second pilar of Grape King Bio.”
Shares of Grape King Bio rose 4.93 percent to NT$149 yesterday, outperforming the TAIEX, which was up 0.44 percent.
Shares of contract chipmaker Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) came under pressure yesterday after a report that Apple Inc is looking to shift some orders from the Taiwanese company to Intel Corp. TSMC shares fell NT$55, or 2.4 percent, to close at NT$2,235 on the local main board, Taiwan Stock Exchange data showed. Despite the losses, TSMC is expected to continue to benefit from sound fundamentals, as it maintains a lead over its peers in high-end process development, analysts said. “The selling was a knee-jerk reaction to an Intel-Apple report over the weekend,” Mega International Investment Services Corp (兆豐國際投顧) analyst Alex Huang
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is expected to remain Apple Inc’s primary chip manufacturing partner despite reports that Apple could shift some orders to Intel Corp, industry experts said yesterday. The comments came after The Wall Street Journal reported on Friday that Apple and Intel had reached a preliminary agreement following more than a year of negotiations for Intel to manufacture some chips for Apple devices. Taiwan Institute of Economic Research (台灣經濟研究院) economist Arisa Liu (劉佩真) said TSMC’s advanced packaging technologies, including integrated fan-out and chip-on-wafer-on-substrate, remain critical to the performance of Apple’s A-series and M-series chips. She said Intel and Samsung
POWER BUILDUP: Powered by Nvidia’s B200 Blackwell chips, the data center would support MediaTek’s computing power demand and business growth, the company said Smartphone chip designer MediaTek Inc (聯發科) yesterday launched a new artificial intelligence (AI) data center with a maximum capacity of 45 megawatts to meet its rising demand for computing power required to develop new advanced chips for AI applications. The company has completed the first-phase computing power buildup at the data center in Miaoli County’s Tongluo Township (銅鑼), providing 15 megawatts of capacity to support its research and development (R&D) capabilities, despite an industrywide shortage of key components, MediaTek said. Supply constraints have plagued a wide range of key components, including memory chips, solid-state drives, power supply units and central
IMAGE SENSORS: The Japanese company would be the controlling shareholder of the venture, with development and production lines to be set up in Kumamoto Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said it has signed a non-binding memorandum of understanding (MOU) with Sony Semiconductor Solutions Corp to create a joint venture to develop and produce next-generation images sensors. The partnership seeks to explore and address emerging opportunities in physical artificial intelligence (AI) applications, such as automotive and robotics, paving the way for innovations and expanded technological advancements, TSMC said in a statement. Sony would be the majority and controlling shareholder of the joint venture, the statement said, adding that the company would set up development and production lines in its newly constructed fab in Kumamoto Prefecture’s
RSS